Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.8.2024Teva B.V. (TEV-NL-4)1210BSastravi 50 mg/12,5 mg/200 mg (tbl flm 100x50 mg/12,5 mg/200 mg (obal HDPE))15.10.2024Z
 13.8.2024POLICHEM S.A. (PLC)70498MACMIROR (tbl obd 20x200 mg (blis.Al/PVC))9.8.2024O
 13.8.2024B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))13.8.2024O
 13.8.2024Zentiva, k.s. (ZNT-1)01077OPHTHALMO-FRAMYKOIN comp. (ung oph 1x5 g (tuba Al))15.8.2024O
 13.8.2024Zentiva, k.s. (ZNT-1)2118DDithiaden (tbl 40x2 mg (blis. PVC/Al))20.8.2024O
 13.8.2024Zentiva, k.s. (ZNT-1)15130BATRAFEN (crm der 1x20 g (tuba Al))7.12.2021R
 13.8.2024Zentiva, k.s. (ZNT-1)06291BATRAFEN (sol der 1x20 ml (nád.PE))18.1.2022R
 12.8.2024Wörwag Pharma GmbH & Co. KG (WGP-1)33922Metfogamma 500 (tbl flm 120x500 mg (blis.PVC/Al))12.8.2024O
 12.8.2024Dr. Falk Pharma GmbH (FAK)93770Salofalk 4 g/60 g Klysmen (sus rec 7x4 g/60 g (fľ.plast.s aplikátorom))12.8.2024O
 12.8.2024Fresenius Kabi AB (FRK-S)06644KABIVEN (emu inf 1x1540 ml (vak Excel))16.8.2024R
 12.8.2024Fresenius Kabi s.r.o. (FRK-CZ-3)33605Sodium chloride Fresenius Kabi 0,9 % (sol inf 10x1 000 ml (fľ.LDPE - KabiPac))16.8.2024R
 12.8.2024Fresenius Kabi s.r.o. (FRK-CZ-3)64499Ceftazidim Kabi 1 g (plv ino 10x1 g (liek.inj.skl.))12.8.2024R
 12.8.2024Fresenius Kabi s.r.o. (FRK-CZ-3)47125Sodium chloride Fresenius Kabi 0,9 % (sol inf 10x1000 ml (vak Freeflex))16.8.2024R
 12.8.2024Fresenius Kabi s.r.o. (FRK-CZ-3)7384DNorepinephrine Kabi 1 mg/ml (con inf 10x1 ml (amp.skl.))12.8.2024O
 12.8.2024B.Braun Melsungen AG (BME)13907Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x1000 ml (fľ.PE))12.8.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)